AU2009303272A1 - Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate - Google Patents
Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate Download PDFInfo
- Publication number
- AU2009303272A1 AU2009303272A1 AU2009303272A AU2009303272A AU2009303272A1 AU 2009303272 A1 AU2009303272 A1 AU 2009303272A1 AU 2009303272 A AU2009303272 A AU 2009303272A AU 2009303272 A AU2009303272 A AU 2009303272A AU 2009303272 A1 AU2009303272 A1 AU 2009303272A1
- Authority
- AU
- Australia
- Prior art keywords
- cpa
- patient
- cyproterone acetate
- day
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13689308P | 2008-10-10 | 2008-10-10 | |
| US61/136,893 | 2008-10-10 | ||
| PCT/US2009/060381 WO2010042930A1 (en) | 2008-10-10 | 2009-10-12 | Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009303272A1 true AU2009303272A1 (en) | 2010-04-15 |
Family
ID=42101000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009303272A Abandoned AU2009303272A1 (en) | 2008-10-10 | 2009-10-12 | Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8288342B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2381946A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012505253A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009303272A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0914024A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2739887A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA022208B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011003726A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010042930A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2345377A1 (de) * | 1973-09-06 | 1975-03-20 | Schering Ag | Pharmazeutische zubereitung i |
| DE2817157A1 (de) * | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
| DE3331824A1 (de) * | 1983-09-01 | 1985-03-21 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen |
| DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
| US4498420A (en) * | 1984-01-23 | 1985-02-12 | Container Corporation Of America | Carton for insects |
| DE3934656A1 (de) * | 1989-10-13 | 1991-04-18 | Schering Ag | Verfahren zur herstellung von waessrigen dispersionen |
| DE3936328A1 (de) * | 1989-10-27 | 1991-05-02 | Schering Ag | Pharmazeutische praeparate |
| IE67345B1 (en) * | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
| US5498420A (en) * | 1991-04-12 | 1996-03-12 | Merz & Co. Gmbh & Co. | Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions |
| BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
| US6165504A (en) * | 1998-09-23 | 2000-12-26 | Barr Laboratories, Inc. | Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients |
| US6613758B1 (en) * | 1999-04-02 | 2003-09-02 | Barr Laboratories, Inc. | Method for treating osteoporosis in castrated prostatic cancer patients |
| FR2821555B1 (fr) * | 2001-03-01 | 2003-05-16 | Besins Int Lab | Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations |
| US20040024230A1 (en) * | 2002-04-29 | 2004-02-05 | Boehringer Ingelheim International Gmbh | Synthesis of cyproterone acetate |
| US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| US7371405B2 (en) * | 2003-12-22 | 2008-05-13 | Mcneil-Ppc, Inc. | Consumer customized dosage forms |
| MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
-
2009
- 2009-10-12 US US12/577,600 patent/US8288342B2/en not_active Expired - Fee Related
- 2009-10-12 MX MX2011003726A patent/MX2011003726A/es active IP Right Grant
- 2009-10-12 EP EP09820034A patent/EP2381946A4/en not_active Withdrawn
- 2009-10-12 JP JP2011531244A patent/JP2012505253A/ja active Pending
- 2009-10-12 AU AU2009303272A patent/AU2009303272A1/en not_active Abandoned
- 2009-10-12 WO PCT/US2009/060381 patent/WO2010042930A1/en not_active Ceased
- 2009-10-12 CA CA2739887A patent/CA2739887A1/en not_active Abandoned
- 2009-10-12 EA EA201170414A patent/EA022208B1/ru not_active IP Right Cessation
- 2009-10-12 BR BRPI0914024A patent/BRPI0914024A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA022208B1 (ru) | 2015-11-30 |
| CA2739887A1 (en) | 2010-04-15 |
| US20100260860A1 (en) | 2010-10-14 |
| EP2381946A1 (en) | 2011-11-02 |
| EP2381946A4 (en) | 2012-08-08 |
| MX2011003726A (es) | 2011-08-17 |
| BRPI0914024A2 (pt) | 2015-11-03 |
| EA201170414A1 (ru) | 2011-10-31 |
| US8288342B2 (en) | 2012-10-16 |
| WO2010042930A1 (en) | 2010-04-15 |
| JP2012505253A (ja) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4965252A (en) | Cholesterol-lowering combination compositions of guar gum and niacin | |
| JP5563227B2 (ja) | ホルモン置換療法のためのドロスピレノン | |
| KR102217942B1 (ko) | 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제 | |
| PT1017390E (pt) | Comprimido revestido que compreende ácido nicotínico ou um composto metabolizado a ácido nicotínico sob uma forma de libertação prolongada, e um revestimento que contém um inibidor da hmg-coa-redutase sob uma forma de libertação imediata. | |
| AU2001225413A1 (en) | Drospirenone for hormone replacement therapy | |
| RS54993B1 (sr) | Terapijski režimi | |
| US6165504A (en) | Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients | |
| EP4649945A1 (en) | Tablet for use in treating huntington's disease and method of making the same | |
| US8288342B2 (en) | Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate | |
| CA2166427A1 (en) | Use of bile acids for preparing medicaments for the treatment of skin diseases | |
| JP2008044879A (ja) | ラクトフェリンを含有する医薬組成物ならびに加工食品 | |
| EP3108889A1 (en) | Drospirenone-based contraceptive for a female patient affected with excess weight | |
| WO2019018158A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| TWI307627B (en) | Drospirenone for hormone replacement therapy | |
| JPH04266822A (ja) | システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤 | |
| HK40101454A (en) | Tablet for use in treating huntington's disease and method of making the same | |
| HK40101454B (en) | Tablet for use in treating huntington's disease and method of making the same | |
| HK40103286A (en) | Methods of treating conditions related to the s1p₁ receptor | |
| HK1255216B (en) | Drospirenone-based contraceptive for a female patient affected with excess weight | |
| HASNIZAN et al. | Inside Stories | |
| CN106265694A (zh) | 用于过重女性患者的基于屈螺酮的避孕药 | |
| SA01210754B1 (ar) | اتحاد صيدلاني من دروسبيرنون drospirenone ممكرن واستروجين estrogen من اجل العلاج كبديل للهرمون |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ AHMED, SALAH U.; SETHIA, SUNDEEP; REAPE, KATHLEEN; HAIT, HOWARD AND BEN-MAIMON, CAROLE S. |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |